Javascript must be enabled to continue!
The Significant Impact of Programmed Cell Death-1 Gene Polymorphism on HBV Infection and Viral Load
View through CrossRef
Background: Hepatitis B virus (HBV) is a common and international problem associated with severe liver diseases. Programmed cell death-1 (PCD-1) is an immunosuppressive molecule that negatively regulates T-cell activity. Genetic variation in PCD-1 gene could impact the encoded protein, and, thus HBV infection.
Objective: To assess the single nucleotide polymorphisms (SNPs) in the PCD-1 gene's promotor area effect of viral load and HBV infection.
Patients and Methods: This case-control study recruited 117 subjects (67 patients with HBV and 50 apparently healthy persons as control). From June 2024 to November 2024, all subjects had been selected at the Gastroenterology and Liver Hospital-Medical City (Baghdad, Iraq). Every participant donates about 5 mL of blood extracted from a vein and stored at -80 °C until it was needed. Blood samples were used to obtain genomic DNA, and gene fragment corresponding the rs38084323 polymorphism in PCD-1 gene was amplified and genotyping by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP).
Results: The patients' and controls' mean ages did not differ significantly, out of the 67 patients, 39 (43.28%) had an acute infection, and 38 (56.7%) had a chronic infection. Merely 34.33% of the patients were receiving HBV-specific therapy. Patients having the mutant homozygous genotype (GG) of rs38084323 were significantly more likely to have it (28.36% vs. 14%) (OR= 3.34, 95%CI= 1.07-10.38, p= 0.037). On the level with allele, the G allele was more often found in patients than in healthy subjects (54.48% vs. 41%), demonstrating an important disparity (OR=1.72, 95% CI=1.02-2.91, p=0.042). The various genotypes did not substantially affect the progression of infection to a chronic status. Although, 30.77% of patients carrying the AA genotype had viral ≥ 200000 IU/ml compared with 5.71% for AG carriers and 15.79% for GG carries with such a viral load, and these results were shown significant difference.
Conclusion: The homozygous mutant genotype (GG) and G allele may be regarded as an indicator of risk for HBV infection. However, their impact on viral load is negligible.
Keywords: Hepatitis B virus, Programmed cell death-1, Promoter, Single nucleotide polymorphism, Apoptosis.
Diyala Journal of Medicine
Title: The Significant Impact of Programmed Cell Death-1 Gene Polymorphism on HBV Infection and Viral Load
Description:
Background: Hepatitis B virus (HBV) is a common and international problem associated with severe liver diseases.
Programmed cell death-1 (PCD-1) is an immunosuppressive molecule that negatively regulates T-cell activity.
Genetic variation in PCD-1 gene could impact the encoded protein, and, thus HBV infection.
Objective: To assess the single nucleotide polymorphisms (SNPs) in the PCD-1 gene's promotor area effect of viral load and HBV infection.
Patients and Methods: This case-control study recruited 117 subjects (67 patients with HBV and 50 apparently healthy persons as control).
From June 2024 to November 2024, all subjects had been selected at the Gastroenterology and Liver Hospital-Medical City (Baghdad, Iraq).
Every participant donates about 5 mL of blood extracted from a vein and stored at -80 °C until it was needed.
Blood samples were used to obtain genomic DNA, and gene fragment corresponding the rs38084323 polymorphism in PCD-1 gene was amplified and genotyping by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP).
Results: The patients' and controls' mean ages did not differ significantly, out of the 67 patients, 39 (43.
28%) had an acute infection, and 38 (56.
7%) had a chronic infection.
Merely 34.
33% of the patients were receiving HBV-specific therapy.
Patients having the mutant homozygous genotype (GG) of rs38084323 were significantly more likely to have it (28.
36% vs.
14%) (OR= 3.
34, 95%CI= 1.
07-10.
38, p= 0.
037).
On the level with allele, the G allele was more often found in patients than in healthy subjects (54.
48% vs.
41%), demonstrating an important disparity (OR=1.
72, 95% CI=1.
02-2.
91, p=0.
042).
The various genotypes did not substantially affect the progression of infection to a chronic status.
Although, 30.
77% of patients carrying the AA genotype had viral ≥ 200000 IU/ml compared with 5.
71% for AG carriers and 15.
79% for GG carries with such a viral load, and these results were shown significant difference.
Conclusion: The homozygous mutant genotype (GG) and G allele may be regarded as an indicator of risk for HBV infection.
However, their impact on viral load is negligible.
Keywords: Hepatitis B virus, Programmed cell death-1, Promoter, Single nucleotide polymorphism, Apoptosis.
Related Results
Modulation of HBV infection and replication by cell-derived factors
Modulation of HBV infection and replication by cell-derived factors
[ACCESS RESTRICTED TO THE UNIVERSITY OF MISSOURI AT REQUEST OF AUTHOR.] Hepatitis B virus (HBV) infection is one of the most serious health problems. HBV infection leads to serious...
Oxidative stress sensor Keap1 recognizes HBx protein to activate the Nrf2/ARE signaling pathway, thereby inhibiting hepatitis B virus replication
Oxidative stress sensor Keap1 recognizes HBx protein to activate the Nrf2/ARE signaling pathway, thereby inhibiting hepatitis B virus replication
ABSTRACT
Hepatitis B virus (HBV) infection promotes reactive oxygen species production while paradoxically inducing the expression of antioxidant enzymes. HBV-induced dis...
Potential Role of Peripheral Blood Lymphocyte Subsets in Rheumatoid Arthritis Patients Concurrent with Hepatitis B Virus Infection:A Retrospective Cohort Study
Potential Role of Peripheral Blood Lymphocyte Subsets in Rheumatoid Arthritis Patients Concurrent with Hepatitis B Virus Infection:A Retrospective Cohort Study
AbstractBackground: Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease. Previous studies have shown that RA patients have high HBV infection rates. Hepatitis B viru...
Abstract P1-15-02: Low incidence of hepatitis B reactivation after chemotherapy in Japanese breast cancer patients with resolved HBV
Abstract P1-15-02: Low incidence of hepatitis B reactivation after chemotherapy in Japanese breast cancer patients with resolved HBV
Abstract
Background: Recently, chemotherapy-induced reactivation of hepatitis B virus (HBV) has been reported not only in patients with HBV surface antigen positive ...
HBV Prophylaxis through vaccination in Romanian dental professionals exposed to Toxoplasma gondii
HBV Prophylaxis through vaccination in Romanian dental professionals exposed to Toxoplasma gondii
Background: Blood borne diseases are important diseases that can transmit their etiological
agents in the medical office. One of the most feared due to its contagious remains hepat...
Triflusal targeting COX-1 suppresses HBV infection in vitro and in vivo
Triflusal targeting COX-1 suppresses HBV infection in vitro and in vivo
Abstract
Background
: Chronic hepatitis B virus infection poses a persistent global public health burden with limited therapeut...
QUANTITATION OF HBV DNA BY REALTIME PCR FOR HBV DETECTION AND FOLLOW-UP VIRAL LOAD IN PATIENTS WITH CHRONICHBV HEPATITIS USING ANTIVIRAL DRUGS
QUANTITATION OF HBV DNA BY REALTIME PCR FOR HBV DETECTION AND FOLLOW-UP VIRAL LOAD IN PATIENTS WITH CHRONICHBV HEPATITIS USING ANTIVIRAL DRUGS
Background: Real-time PCR assay has been routinely used in many laboratories for HBV determination and follow –up of the HBV DNA levels in serum of chronic HBV patients during anti...
Effectiveness of zero dose HBV vaccine on prevention of HBV breakthrough infection among vaccinated Egyptian children
Effectiveness of zero dose HBV vaccine on prevention of HBV breakthrough infection among vaccinated Egyptian children
Hepatitis B virus (HBV) is a vaccine preventable disease. Sufficient post vaccination response is critical step to achieve infection eradication. Vaccine hypo-responsiveness is a m...

